Less Ads, More Data, More Tools Register for FREE

Pin to quick picksACTA.L Regulatory News (ACTA)

  • There is currently no data for ACTA

Additional Listing

26 Mar 2008 07:00

Acta S.p.A.26 March 2008 26 March 2008 Acta S.p.A (the "Company") Additional Listing In connection with the completion of the second tranche of the Sumitomoinvestment, first announced on 12 July 2007, the Company has applied for2,000,000 new ordinary shares of EUR 0.006 each in the Company to be admitted totrading on the AIM ("Admission"). Admission of these shares is expected to occuron 28 March 2008. For further information please contact: Acta S.p.A Tel. + 44 (0) 20 7360 4900Toby Woolrych Smithfield Group Tel. +44 (0) 20 7903 0603George Hudson, Katie Hunt, Will Henderson Numis as Nominated Advisor and Broker Tel. +44 (0) 20 7260 1000Jag Mundi, David Poutney, Alex Ham Notes to Editors: Acta S.p.A. Acta develops and manufactures unique patented catalysts which have beenlaunched initially to the hydrogen generation, portable power and waste toenergy markets. Acta's catalysts for ammonia decomposition into hydrogen offer the automotiveindustry access to a practical hydrogen carrier for the first time. Thecatalysts extract hydrogen from ammonia at room temperature, allowing ammonia,one of the most widely used chemicals in the world, to become a fuel forautomotive use, solving the problem of hydrogen storage and transportation. Acta's catalyst range for alkaline membrane fuel cells allows fuel celldevelopers to stop using expensive platinum so that fuel cells can be madecommercially viable for mass adoption, particularly in automotive and portableelectronics applications. Adoption of HYPERMEC catalysts greatly reduces thecost of fuel cells and additionally allows for the first time the use of a widerange of safe liquid bio-fuels such as ethanol and glycerol. Simple passivealkaline membrane fuel cells can act as a high performance and environmentallyfriendly alternative to lead acid and alkaline batteries at a commerciallyacceptable price. Acta is also developing other commercial opportunities using its catalysts forwaste treatment in the bio-fuel, polymer and other industries. Acta listed on AIM in October 2005. Sumitomo Partnership and Investment Acta has a long term marketing agreement with Sumitomo Corporation, a leadingJapanese trading corporation, which confers enormous competitive advantage toActa when doing business with major Asian customers. Acta announced in July a£4.6m investment by Sumitomo Corporation together with a further £1.15m placingwith UK institutions. At the same time Acta and Sumitomo entered into a newMarketing Agreement with the initial fixed term extended to ten years and provisions contemplating collaboration in future ventures in the Asian region. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
22nd Sep 20107:00 amRNSInterim Results
4th Aug 20107:01 amRNS2.7 MW Photovoltaic Project Consents Received
20th Jul 20107:01 amRNSService Station Agreement
20th Jul 20107:00 amRNSChange of Adviser
13th Jul 20105:19 pmRNSTR-1: Notification of Major Interest in Shares
13th Jul 20107:00 amRNSPositive Response to New Italian Feed-in-Tariff
1st Jul 20105:53 pmRNSIssue of Equity
1st Jul 201012:16 pmRNSActa exhibits at Goodwood Festival of Speed
29th Jun 20107:00 amRNSResult of AGM & marketing update
10th Jun 201010:52 amRNSActa unveils world's first hydrogen-powered tender
9th Jun 20108:00 amRNSChange of web site address
2nd Jun 20107:15 amRNSAnnual Financial Report
2nd Jun 20107:00 amRNSRe Contract
28th Apr 20107:00 amRNSAward of grant
22nd Apr 20107:00 amRNSHydrogen fuel enrichment test results
26th Mar 20105:05 pmRNSDirector/PDMR Shareholding
25th Mar 20107:00 amRNSPreliminary Results
23rd Mar 20107:00 amRNSPhotovoltaics Programme
3rd Mar 20107:00 amRNSSumitomo Corporation Distribution Agreement
15th Feb 20107:00 amRNSHydrogen Generator wins Qualitec Technology Award
2nd Feb 20107:00 amRNSTrading Update
20th Jan 20107:00 amRNSDirector/PDMR Shareholding
10th Dec 20098:50 amRNSTrade Show & Product Launch Update
25th Nov 20097:00 amRNSDevelopment Contract
22nd Oct 20097:00 amRNSProduct Launch Confirmation
24th Sep 20097:00 amRNSHalf Yearly Report
23rd Sep 20099:55 amRNSNotice of Forthcoming Interim Results Statement
10th Aug 20097:00 amRNSProduct Launch Update
22nd Jul 200912:08 pmRNSStatement re price movement
17th Jul 20097:00 amRNSTrading Update
25th Jun 20095:16 pmRNSResult of AGM
1st Jun 20097:00 amRNSPosting of Annual Report
28th May 20097:00 amRNSGrant of Options
26th Mar 20097:00 amRNSFinal Results
29th Jan 200910:39 amRNSDirectorate Change
26th Jan 20097:00 amRNSGrant Approval
22nd Jan 20097:00 amRNSTrading Statement
21st Jan 20092:06 pmRNSDirector Declaration
19th Jan 20097:00 amRNSChange of Adviser
7th Nov 20087:00 amRNSRe Contract
13th Oct 20081:11 pmRNSDirector/PDMR Shareholding
1st Oct 20087:00 amRNSDirector/PDMR Shareholding
24th Sep 20087:00 amRNSInterim Results
5th Sep 20084:47 pmRNSTrading Update
3rd Sep 20087:00 amRNSNotice of Results
23rd Jul 20087:00 amRNSCatalyst Launch Programme
17th Jul 20087:00 amRNSTrading Statement
23rd Jun 20087:00 amRNSDirectorate Change
10th Jun 20087:00 amRNSAGM Statement
30th Apr 20087:00 amRNSAnnual Report and Accounts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.